Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lyrdal

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Acta Oncologica (Stockholm, Sweden)|March 11, 2009
Metastatic renal cell carcinoma treated with Peg-interferon alfa-2bDavid Lyrdal, Ulrika Stierner, Sven Lundstam
Acta Radiologica (Stockholm, Sweden : 1987)|November 22, 2014
Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal massesMats Andersson, Farida Hashimi, David Lyrdal, et al.
Scandinavian Journal of Urology|January 24, 2020
Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillanceJesper Swärd, Olof Henrikson, David Lyrdal, et al.
Scandinavian Journal of Urology|November 10, 2012
Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001David Lyrdal, Frank Aldenborg, Erik Holmberg, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2003
Nephron-sparing surgery for renal cell carcinoma--long-term resultsSven Lundstam, Olof Jonsson, David Lyrdal, et al.
Nuclear Medicine Communications|June 13, 2009
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomographyDavid Lyrdal, Marianne Boijsen, Madis Suurküla, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 17, 2010
Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-upDavid Lyrdal, Mats Andersson, Mikael Hellström, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|March 11, 2009
Metastatic renal cell carcinoma treated with Peg-interferon alfa-2bDavid Lyrdal, Ulrika Stierner, Sven Lundstam
Acta Radiologica (Stockholm, Sweden : 1987)|November 22, 2014
Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal massesMats Andersson, Farida Hashimi, David Lyrdal, et al.
Scandinavian Journal of Urology|January 24, 2020
Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillanceJesper Swärd, Olof Henrikson, David Lyrdal, et al.
Scandinavian Journal of Urology|November 10, 2012
Kidney cancer in Sweden: a decrease in incidence and tumour stage, 1979 - 2001David Lyrdal, Frank Aldenborg, Erik Holmberg, et al.
Scandinavian Journal of Urology and Nephrology|August 29, 2003
Nephron-sparing surgery for renal cell carcinoma--long-term resultsSven Lundstam, Olof Jonsson, David Lyrdal, et al.
Nuclear Medicine Communications|June 13, 2009
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomographyDavid Lyrdal, Marianne Boijsen, Madis Suurküla, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 17, 2010
Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-upDavid Lyrdal, Mats Andersson, Mikael Hellström, et al.
Pageof 1